Received Oct 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
Poor sleep; Chills; Some nauseum; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and NAUSEA (Some nauseum) in a 44-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Influenza vaccine on 16-Sep-2025. Past adverse reactions to the above products included No adverse effect with Influenza vaccine. On 02-Oct-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On 02-Oct-2025, the patient experienced POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and NAUSEA (Some nauseum). The patient was treated with Ibuprofen (Advil) for Poor sleep, at an unspecified dose and frequency. On 03-Oct-2025, POOR QUALITY SLEEP (Poor sleep), CHILLS (Chills) and NAUSEA (Some nauseum) had resolved. The action taken with mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) was unknown. Concomitant medication was not provided. Patient did not have medical history, concomitant disease or risk factors. Patient did not experience any additional symptoms or events.